Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

"Mechel summarized its results in the first half of the year

8/29/23 MTLR

Polyus in the first half of the year increased gold production by 36%

8/29/23 PLZL

Polyus reported for 6 months of 2023 by IFRS

8/29/23 PLZL

Kamaz resumes production of trucks with Euro-5 engine

8/29/23 KMAZ

Yuzhuralnickel reported for 6 months of 2023 by IFRS

8/29/23 UNKL

Slavneft-Yaroslavnefteorgsintez reported for 6 months of 2023 by IFRS

8/29/23 JNOS

Permenergosbyt reported for 6 months of 2023 by IFRS

8/29/23 PMSB

Board of Directors of Donskoy Factory of Radiocomponents recommended that dividends be paid for 6 months 2023

8/29/23 DZRD

Shareholders of TMK approved dividends for 6 months 2023

8/29/23 TRMK

Xiaomi reported for 6 months of 2023

8/29/23 1810